Project Number 1R43AG078093-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) e. Neurogenesis Researcher and Organization Principal Investigator VALAT, ANNE Principal Investigator First Name ANNE Principal Investigator Last Name VALAT Awardee Organization BOLDEN THERAPEUTICS, INC. Awardee State Rhode Island Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $497,550 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
